Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 750 of 1475 entries
View as:

A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)

Phase: N/A Priority: Normal
NCT ID: NCT06035497 Org: User:
Start: 11/20/23 End: 10/10/30 Due: 10/10/31

A Study to Evaluate Effectiveness and Safety of Deucravacitinib in Participants With Non-Pustular Palmoplantar and Genital Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT06042920 Org: User:
Start: 10/09/23 End: 04/25/25 Due: 04/25/26

Phase III Daclatasvir, Sofosbuvir, and Ribavirin in Cirrhotic Participants and Participants Post-liver Transplant

Phase: N/A Priority: Normal
NCT ID: NCT02032875 Org: User:
Start: 03/31/14 End: 01/31/16 Due: 01/31/17

A Study to Assess Safety of Nivolumab in Routine Oncology Practice in China

Phase: N/A Priority: Normal
NCT ID: NCT04825873 Org: User:
Start: 05/28/21 End: 02/13/23 Due: 02/13/24

A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation

Phase: N/A Priority: Normal
NCT ID: NCT02981472 Org: User:
Start: 01/19/17 End: 10/18/21 Due: 10/18/22

A Phase 2b Evaluation of Daclatasvir/Sofosbuvir in Non-Cirrhotic Treatment Naive Subjects With Genotype 1, 2, 3 and 4 Chronic Hepatitis C Virus Coinfected With Human Immunodeficiency Virus (HIV-1)

Phase: N/A Priority: Normal
NCT ID: NCT02556086 Org: User:
Start: 12/31/15 End: 07/31/17 Due: 07/31/18

A Study of Effectiveness and Safety of the First-Line Nivolumab Plus Ipilimumab With or Without Chemotherapy for Advanced/Recurrent Non-Small Cell Lung Cancer in Japan

Phase: N/A Priority: Normal
NCT ID: NCT05161325 Org: User:
Start: 12/15/20 End: 05/31/23 Due: 05/31/24

A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT05744466 Org: User:
Start: 09/30/22 End: 12/10/27 Due: 12/10/28

Safety Study of Abatacept to Treat Rheumatoid Arthritis (B)

Phase: N/A Priority: Normal
NCT ID: NCT01088360 Org: User:
Start: 03/31/05 End: 06/30/29 Due: 06/30/30

A Study of Patients Receiving Adjuvant Nivolumab Therapy for Melanoma That Has Been Removed

Phase: N/A Priority: Normal
NCT ID: NCT03771859 Org: User:
Start: 01/16/19 End: 12/30/25 Due: 12/30/26

Phase 1 Oral Solution Bioavailability Study of Apixaban When Administered Through a Nasogastric Tube in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02034578 Org: User:
Start: 07/31/11 End: 08/31/11 Due: 08/31/12

Methotrexate-Inadequate Response Autoinjector Device Sub Study

Phase: N/A Priority: Normal
NCT ID: NCT01844895 Org: User:
Start: 04/30/13 End: 07/31/14 Due: 07/31/15

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Phase: N/A Priority: Normal
NCT ID: NCT01244750 Org: User:
Start: 12/02/10 End: 01/08/20 Due: 01/08/21

Ascending Multiple-Dose Study of BMS-817378 in Subjects With Advanced Cancers

Phase: N/A Priority: Normal
NCT ID: NCT00792558 Org: User:
Start: 01/31/09 End: 11/30/10 Due: 11/30/11

Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BMS-779788 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00836602 Org: User:
Start: 02/28/09 End: 07/31/09 Due: 07/31/10

Safety, Tolerability, and Pharmacokinetics of KarXT and Dual-burst Release of Xanomeline With Immediate-release Trospium Chloride in Adolescents With Psychiatric Disorders

Phase: N/A Priority: Normal
NCT ID: NCT06853171 Org: User:
Start: 04/29/25 End: 01/03/26 Due: 01/03/27

A Study of BMS-986504 in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion

Phase: N/A Priority: Normal
NCT ID: NCT06855771 Org: User:
Start: 05/30/25 End: 12/30/31 Due: 12/30/32

Study of BMS-582664 in Combination With Either FOLFIRI or FOLFOX for Gastrointestinal (GI) Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00300027 Org: User:
Start: 04/30/06 End: - Due: -

Entecavir Plus Adefovir in Lamivudine-Resistant Patients

Phase: N/A Priority: Normal
NCT ID: NCT00986778 Org: User:
Start: 12/31/09 End: 06/30/14 Due: 06/30/15

Post-marketing Safety Surveillance Program in Human Immunodeficiency Virus (HIV)-Infected Children Exposed to Atazanavir in Europe

Phase: N/A Priority: Normal
NCT ID: NCT01389310 Org: User:
Start: 07/31/11 End: 02/28/14 Due: 02/28/15

Safety and Efficacy of Daclatasvir (BMS-790052) Plus Standard of Care (Pegylated-interferon Alpha-2b and Ribavirin) in Japanese Patients

Phase: N/A Priority: Normal
NCT ID: NCT01016912 Org: User:
Start: 12/31/09 End: 09/30/10 Due: 09/30/11

A Randomized, Placebo-Controlled Trial of BMS-275291 Given Daily for 12 Months to Women With Stage 1c-IIIA Breast Cancer Receiving Adjuvant Chemotherapy and/or Hormonal Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00036621 Org: User:
Start: - End: - Due: -

A Study of Multiple Immune and Disease Treatment Combinations in Participants With ER+HER2- Breast Cancer That Has Spread

Phase: N/A Priority: Normal
NCT ID: NCT04132817 Org: User:
Start: 09/22/20 End: 08/15/22 Due: 08/15/23

Drug Interaction Study of an OCP (Norethindrone (ND) Acetate and Ethinyl Estradiol (EE))With a Combination of Daclatasvir (DCV) Asunaprevir (ASV) and BMS-791325

Phase: N/A Priority: Normal
NCT ID: NCT02103569 Org: User:
Start: 04/30/14 End: 07/31/14 Due: 07/31/15

A Study to Evaluate the Effect of Omeprazole on the Pharmacokinetics of BMS-986205 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03936374 Org: User:
Start: 05/08/19 End: 07/20/19 Due: 07/20/20